Enliven Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
CELC
Celcuity Inc. |
$13.17 | $501.59 M | -5.14 | 55 | $0 |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
CMPX
Compass Therapeutics, Inc. |
$1.58 | $180.24 M | -3.74 | 35 | $0 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
GOSS
Gossamer Bio, Inc. |
$1.09 | $124.06 M | -0.65 | 135 | $0 |
GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
IMRX
Immuneering Corporation |
$2.36 | $40.63 M | -0.74 | 66 | $0 |
INBX
Inhibrx Biosciences, Inc. |
$16.52 | $241.02 M | -1.44 | 166 | $1.80 M |
KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
MACK
Merrimack Pharmaceuticals, Inc. |
$15.15 | $223.75 M | -168.11 | 0 | $0 |
MLTX
MoonLake Immunotherapeutics |
$51.75 | $2.62 B | -57.88 | 100 | $0 |
NVCT
Nuvectis Pharma, Inc. |
$6.61 | $116.38 M | -4.5 | 13 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.57 | $85.40 M | -1.26 | 47 | $0 |
REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
